12.01.2018 Issue 150

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Associate Director, Health Economics & Outcomes Research

The Associate Director of HEOR will help drive health economics and outcomes research activities in support of products in the rare genetic disease (RGD) and hematology/oncology portfolio.

Researcher - HEOR

Executive Director, Health Technology Assessment (HTA) Statistics (U.S.)

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Health Economics and Outcomes Associate Consultant

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Report: Pharma, U.K. Reach Deal on Pricing, Access

FDA Has Big Changes Planned for Medical Device Approval Pipeline

Patients in China Turn to Drastic Measures to Get Much-Needed Care

Apple, VA in Talks Over Portable EHRs for Veterans

Industry Spotlight

Conferences Webinars
Principles of Pharma Market Access in Europe
    December 4-5, Brussels, Belgium

Bio/Pharma Compliance Congress on Non-Promotional Activities
    December 4-5, Philadelphia, Pennsylvania

Value Pricing for Market Access
    December 6-7, Brussels, Belgium

15th Clinical Performance Metrics Summit
    December 6-7, Philadelphia, Pennsylvania

New Requirements for Selling Devices in the European Union
    December 3

2018 Midterm Elections and Implications for Health Care
    December 3

Population-based Care Management: How Health Plans Can Leverage PHM Solutions for Value-based Care (Part II)
    December 6

Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA’s Expanded Access
    December 11

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Big Data in Pharmaceuticals: Big Opportunities or Big Challenges – or Both?

Health Care USA: A Cancer on the American Dream

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven